'World-first' vaccine designed by artificial intelligence | BBC/Getty Images
Scientists in Cambridge say they have taken a major step toward building vaccines that could protect against entire families of viruses—including future threats that have not yet emerged.
A research team from the University of Cambridge and biotechnology spin-out DIOSynVax has successfully completed the first human trial of a new “universal” coronavirus vaccine designed using artificial intelligence.
A Thursday report obtained by our correspondent from the varsity’s website and titled, “New ‘universal vaccine’ technology could protect us from future virus outbreaks,” disclosed this.
The early-stage trial involved 39 healthy volunteers and found the vaccine to be safe, with no significant side effects reported.
